Christopher Gallardo Selected Research

Therapeutics

1/2018	Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged rats.
1/2017	Conditional Deletion of Prnp Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher Gallardo Research Topics

Disease

2	Parkinson Disease (Parkinson's Disease) 10/2019 - 11/2018
2	Dementia (Dementias) 11/2018 - 05/2014
2	Memory Disorders (Memory Loss) 01/2018 - 01/2017
1	Body Weight (Weight, Body) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Psychotic Disorders (Schizoaffective Disorder) 05/2014

Drug/Important Bio-Agent (IBA)

1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2019
1	SynucleinsIBA 11/2018
1	CorticosteroneIBA 01/2018
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2018
1	R 121919IBA 01/2018
1	antalarminIBA 01/2018
1	Prion ProteinsIBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	Antipsychotic Agents (Antipsychotics)IBA 05/2014

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2017